Thomas Hughes leaves Zafgen to take CEO role at Navitor Thomas Hughes, Ph.D., has left Zafgen to become CEO at mTORC1 startup Navitor Pharmaceuticals. Hughes helmed Zafgen through a turbulent […]
CAR-T player Cellectis poaches Stefan Scherer from Novartis Cellectis has named Stefan Scherer, M.D., Ph.D., as its SVP of clinical development. Scherer joins the off-the-shelf CAR-T pioneer from Novartis, where […]
Fortress Bio’s in-house stockbrokers raised 0M to support its young biotechs: Reuters Fortress Biotech used its own, in-house brokerage firm, National Securities, to raise at least $240 million from thousands […]
A better enzyme for CRISPR gene editing? The gene editing system CRISPR-Cas9 is promising for its potential to treat diseases caused by gene irregularities, but fears of off-target effects threaten […]
Regeneron plots DTC advertising and discount push to put Eylea back on track Industry watchers already knew that Regeneron’s key new launches were hitting their marks, thanks to quarterly numbers […]